Basic Vector Information
- Vector Name:
- pmGFP-ADAR1-p110
- Antibiotic Resistance:
- Ampicillin
- Length:
- 8916 bp
- Type:
- Mammalian Expression
- Replication origin:
- ori
- Selection Marker:
- Neomycin (select with G418)
- Promoter:
- CMV
- Cloning Method:
- Restriction Enzyme
- 5' Primer:
- AAAGGGaagcttATGGCCGAGATCAAGGAGAAAATC
- 3' Primer:
- AAAGGGtctagaCTATACTGGGCAGAGATAAAAGTTC
pmGFP-ADAR1-p110 vector Vector Map
Plasmid Resuspension Protocol:
1. Centrifuge at 5,000×g for 5 min.
2. Carefully open the tube and add 20 μl of sterile water to dissolve the DNA.
3. Close the tube and incubate for 10 minutes at room temperature.
4. Briefly vortex the tube and then do a quick spin to concentrate the liquid at the bottom. Speed is less than 5000×g.
5.Store the plasmid at -20 ℃.
pmGFP-ADAR1-p110 vector Sequence
LOCUS 40924_30775 8916 bp DNA circular SYN 13-MAY-2021 DEFINITION ADAR1-p110 expression plasmid.. ACCESSION . VERSION . KEYWORDS . SOURCE synthetic DNA construct ORGANISM synthetic DNA construct REFERENCE 1 (bases 1 to 8916) AUTHORS Galipon J, Ishii R, Suzuki Y, Tomita M, Ui-Tei K TITLE Differential Binding of Three Major Human ADAR Isoforms to Coding and Long Non-Coding Transcripts. JOURNAL Genes (Basel). 2017 Feb 11;8(2). pii: genes8020068. doi: 10.3390/genes8020068. PUBMED 28208661 REFERENCE 2 (bases 1 to 8916) TITLE Direct Submission REFERENCE 3 (bases 1 to 8916) AUTHORS . TITLE Direct Submission COMMENT SGRef: number: 1; type: "Journal Article"; journalName: "Genes (Basel)."; date: "2017-02-11"; pages: " 10.3390/genes8020068" COMMENT SGRef: number: 2; type: "Journal Article" FEATURES Location/Qualifiers source 1..8916 /mol_type="other DNA" /organism="synthetic DNA construct" polyA_signal 3405..3629 /label=bGH poly(A) signal /note="bovine growth hormone polyadenylation signal" rep_origin 3675..4103 /label=f1 ori /note="f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis" promoter 4117..4446 /label=SV40 promoter /note="SV40 enhancer and early promoter" CDS 4513..5304 /codon_start=1 /label=NeoR/KanR /note="aminoglycoside phosphotransferase" /translation="MIEQDGLHAGSPAAWVERLFGYDWAQQTIGCSDAAVFRLSAQGRP VLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLS SHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVADRYQDIA LATRDIAEELGGEWADRFLVLYGIAAPDSQRIAFYRLLDEFF" polyA_signal 5481..5614 /label=SV40 poly(A) signal /note="SV40 polyadenylation signal" primer_bind complement(5651..5667) /label=M13 rev /note="common sequencing primer, one of multiple similar variants" protein_bind complement(5675..5691) /label=lac operator /note="The lac repressor binds to the lac operator to inhibit transcription in E. coli. This inhibition can be relieved by adding lactose or isopropyl-beta-D-thiogalactopyranoside (IPTG)." promoter complement(5699..5729) /label=lac promoter /note="promoter for the E. coli lac operon" protein_bind complement(5744..5765) /label=CAP binding site /note="CAP binding activates transcription in the presence of cAMP." rep_origin complement(6053..6641) /direction=LEFT /label=ori /note="high-copy-number ColE1/pMB1/pBR322/pUC origin of replication" CDS complement(6815..7672) /codon_start=1 /label=AmpR /note="beta-lactamase" /translation="MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYI ELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYS PVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRW EPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSA LPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGAS LIKHW" promoter complement(7673..7777) /label=AmpR promoter enhancer 8043..8422 /label=CMV enhancer /note="human cytomegalovirus immediate early enhancer" promoter 8423..8626 /label=CMV promoter /note="human cytomegalovirus (CMV) immediate early promoter" promoter 8671..8689 /label=T7 promoter /note="promoter for bacteriophage T7 RNA polymerase" CDS join(8756..8916,1..556) /codon_start=1 /label=EGFP /note="enhanced GFP" /translation="MVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTL KFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDD GNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIK VNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLL EFVTAAGITLGMDELYK"
This page is informational only.